Search

Displaying results 6301 - 6310 of 10000 in total
  1. Drug

    VTP-201227

    go.drugbank.com/drugs/DB05652
    Experimental

    VTP-201227 has a novel mechanism of action and is being developed as a topical agent for the treatment of psoriasis with potential extensions into other dermatological indications. … It is being developed by Vitae Pharmaceuticals.

  2. Drug

    Afizagabar

    go.drugbank.com/drugs/DB21439
    Investigational

    Afizagabar is a small molecule drug. Afizagabar is under investigation in clinical trial NCT02877615 (Efficacy and Safety Trial With S 44819 After Recent Ischemic Cerebral Event). … Afizagabar has a monoisotopic molecular weight of 365.06 Da.

    Categories: GABA-A Receptor Antagonists, Heterocyclic Compounds, 1-Ring
  3. Drug

    RD06-04

    go.drugbank.com/drugs/DB24647
    Investigational

    RD06-04 is a biologic drug. … RD06-04 is under investigation in clinical trial NCT06986018 (Clinical Study on the Targeted CD19 Universal CAR-T Cell Injection (RD06-04) for the Treatment of IIM and AAV).

  4. Drug

    ARI-0001

    go.drugbank.com/drugs/DB30635
    Investigational

    ARI-0001 is a biologic drug. ARI-0001 is under investigation in clinical trial NCT05641428 (Comparison of Point-of-care Produced CAR T-cell with Commercial CAR T-cells in Patients with R/R LBCL).

  5. Drug

    Amniotic membrane

    go.drugbank.com/drugs/DB33970
    Experimental

    Amniotic membrane is a biologic drug. … Amniotic membrane is under investigation in clinical trial NCT07824596 (The Role of Amniotic Membrane in Promoting Rapid Recovery of Buccal Mucosal Defect After Harvesting Oral Mucosa for Urethral Reconstruction

  6. Drug

    Dasotraline

    go.drugbank.com/drugs/DB12305
    Investigational

    Dasotraline is a serotonin, norepinephrine and dopamine reuptake inhibitor (SNDRI) that is under investigation for the treatment of Binge Eating Disorder, Adult Attention Hyperactivity Disorder, Attention

  7. Drug

    Anthramycin

    go.drugbank.com/drugs/DB19555
    Experimental

    Anthramycin is a small molecule drug. The usage of the INN stem '-mycin' in the name indicates that Anthramycin is a antibiotic, produced by Streptomyces strain. … Anthramycin has a monoisotopic molecular weight of 315.12 Da.

    Categories: Heterocyclic Compounds, 2-Ring, Heterocyclic Compounds, 3-Ring
  8. Drug

    Nitraquazone

    go.drugbank.com/drugs/DB19659
    Experimental

    Nitraquazone is a small molecule drug. The usage of the INN stem '-azone' in the name indicates that Nitraquazone is a anti-inflammatory analgesic, phenylbutazone derivative. … Nitraquazone has a monoisotopic molecular weight of 311.09 Da.

    Categories: Heterocyclic Compounds, 2-Ring
  9. Drug

    Isoxepac

    go.drugbank.com/drugs/DB19733
    Experimental

    Isoxepac is a small molecule drug. The usage of the INN stem '-ac' in the name indicates that Isoxepac is a anti-inflammatory agent, ibufenac derivative. … Isoxepac has a monoisotopic molecular weight of 268.07 Da.

    Synonyms: Olopatadine related compound c
  10. Drug

    Apalcillin

    go.drugbank.com/drugs/DB19777
    Experimental

    Apalcillin is a small molecule drug. The usage of the INN stem '-cillin' in the name indicates that Apalcillin is a antibiotic, 6-aminopenicillanic acid derivative. … Apalcillin has a monoisotopic molecular weight of 521.14 Da.

    Categories: Penicillin G, Heterocyclic Compounds, 2-Ring